Transforming IMP into Clinical Supply: An Integrated Approach
Summary: The end-to-end development process for creating new drug products can be very complex. From early formulation through clinical trials, sponsors are actively working to ensure their investigational medicinal product (IMP) is appropriately developed for its indication and patients. With increased competition out in the market today, sponsors are also trying to speed up timelines to get their product to commercial launch faster, without sacrificing drug efficacy or safety. Working with a development and supply partner that offers integrated solutions can help sponsors meet these requirements.